4.2 Article

c-Jun expression in human neuropathies: a pilot study

Journal

JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
Volume 16, Issue 4, Pages 295-303

Publisher

WILEY-BLACKWELL
DOI: 10.1111/j.1529-8027.2011.00360.x

Keywords

axonal neuropathy; c-Jun; Schwann cell; skin biopsy

Funding

  1. UCLH Charities Clinical Research and Development committee
  2. Medical Research Council (MRC)
  3. Muscular Dystrophy Campaign
  4. National Institutes of Neurological Diseases and Stroke and Office of Rare Diseases [U54NS065712]
  5. Department of Health's National Institute for Health Research Biomedical Research Centre
  6. Medical Research Council [G1001253, G0802760, G108/638] Funding Source: researchfish
  7. MRC [G0802760, G1001253, G108/638] Funding Source: UKRI

Ask authors/readers for more resources

Schwann cell dedifferentiation following nerve injury is important to permit neural survival and axonal regrowth. Animal studies have shown that the transcription factor c-Jun is upregulated in Schwann cells of injured and pathological nerves where it acts as an important regulator of Schwann cell plasticity, promoting dedifferentiation and demyelination. This pilot immunohistochemical study investigates whether c-Jun is also upregulated in human neuropathies. We examined c-Jun expression in normal and diseased human nerves, as well as in dermal myelinated nerve fibres. Our findings show that although as predicted c-Jun is rarely expressed in normal nerves, it is expressed in Schwann cell nuclei of pathological nerves as predicted by animal studies. Pathological dermal myelinated nerve fibres also show clear nuclear c-Jun expression. Further studies of c-Jun expression will help clarify its role in human neuropathies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available